# Pelthos Therapeutics (PTHS) — Overview

PTHS · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/pths

## Price

Last close $20.26 on Oct 15, 2026. 52-week range $18.19 – $37.42.

## Company profile

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $43.3M |
| Revenue (quarter) | $15.6M |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $34.0M |
| Gross margin | 78.59% |
| Net income (trailing twelve months) | −$86.4M |
| Net income (quarter) | −$23.4M |
| Net income growth (year over year) | -578.95% |
| Net margin | -199.50% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$28.63 |
| Book value per share | −$0.40 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 101.09% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Pelthos Therapeutics (PTHS) profitable?

No. Pelthos Therapeutics reported a net loss of $86.4M over the trailing twelve months.

### How much revenue does Pelthos Therapeutics (PTHS) make?

Pelthos Therapeutics generated $43.3M in revenue over the trailing twelve months.

### How do I buy stock in Pelthos Therapeutics (PTHS)?

PTHS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).